What is dosist?
Founded in 2016 and headquartered in Santa Monica, California, dosist has carved out a distinct niche by integrating precision technology with natural health management. The company specializes in dose-controlled cannabis therapy, a methodology designed to provide consumers with consistent, predictable, and safe experiences. By prioritizing scientific rigor and user-centric design, dosist has positioned itself as a leader in the wellness-tech vertical, effectively bridging the gap between traditional pharmaceutical standards and consumer-facing health products. Their market position is defined by a focus on efficacy and reliability, which has allowed them to navigate the complex regulatory environment of the cannabis industry while maintaining a premium brand identity.
How much funding has dosist raised?
dosist has raised a total of $15M across 1 funding round:
Private Equity
$15M
Private Equity (2020): $15M with participation from Turning Point Brands, Inc.
Key Investors in dosist
Turning Point Brands, Inc.
A manufacturer and marketer of branded consumer products, including tobacco and vaping items, with a strategic interest in the evolving cannabis and wellness markets.
What's next for dosist?
With the recent influx of financing, dosist is well-positioned to accelerate its operational footprint and deepen its research and development capabilities. The strategic focus will likely shift toward expanding distribution channels and enhancing the technological infrastructure that supports their dose-controlled delivery systems. As the company moves into this next phase of growth, the emphasis will remain on scaling production to meet rising consumer demand for standardized, natural health alternatives. By leveraging this capital, dosist aims to solidify its leadership in the wellness sector, potentially exploring new product categories and geographic markets that align with their mission of empowering health and happiness through innovation. The company's trajectory suggests a transition from a high-growth startup to an established enterprise-level entity capable of sustained market influence.
See full dosist company page
